CLOUDMD SOFTWARE & SVCS - DOCRF STOCK NEWS

CloudMD Software & Services (OTCQX: DOCRF) announced its fourth quarter and full year earnings call for the year ended December 31, 2021, scheduled for May 3, 2022. Audited financial statements will be released on the same day. The company focuses on transforming healthcare delivery through technology, emphasizing a patient-centric approach. CloudMD caters to over 5,700 clinicians and services 12 million lives in North America. Its business model includes Clinics and Pharmacies, Digital Solutions, and a rapidly growing Enterprise Health Solutions Division.

CloudMD Software & Services announced the appointment of Mr. Gaston Tano to its Board of Directors, enhancing its financial governance. Tano, a seasoned finance executive with over 30 years of experience, previously held senior positions at Shawcor, Spin Master, and CCL Industries. Interim CEO Karen Adams expressed confidence that Tano's expertise will bolster the Company's growth and governance as it aims for sustainable profitability. The Board is expected to expand further, underscoring CloudMD's commitment to strong leadership and financial acumen.

CloudMD Software & Services announced that it will release its audited financial results for the year ended December 31, 2021, on May 2, 2022, after market close. A conference call will follow at 5:00 pm ET to discuss the results, featuring operational highlights and a Q&A session. CloudMD leverages technology to transform healthcare delivery, servicing over 5,700 clinicians and covering 12 million lives across North America through its various health services and solutions.

CloudMD Software & Services Inc. (OTCQX: DOCRF) announced the resignation of Mark Kohler as a director and Chair of the Board, effective April 21, 2022, citing personal reasons. The Company expressed gratitude for his contributions during his tenure. CloudMD is focused on transforming healthcare delivery through technology, offering a comprehensive platform that covers all aspects of a patient's healthcare journey, servicing over 5,700 clinicians, including various specialists, and covering 12 million lives across North America.

CloudMD Software & Services Inc. announced the departure of founder Dr. Essam Hamza as CEO effective May 2, 2022. He will transition to a strategic advisor role while remaining on the Board of Directors. Karen Adams, the current President, has been appointed Interim CEO. Under Dr. Hamza's leadership, CloudMD grew significantly, completing over 15 acquisitions projected to add $100 million in annual revenue. Adams brings over 25 years of healthcare experience, having driven revenue growth and geographic expansion during her tenure.

CloudMD Software & Services Inc. (DOCRF) announced the elimination of $7.5 million in annualized run-rate costs through cost optimization strategies focused on enhancing operational efficiency. This exceeds the previously anticipated $4 million in savings and is expected to generate full benefits in Q2 2022. The company's strategic restructuring aims to streamline operations, reinforce customer service, and bolster cross-selling opportunities within its healthcare solutions. Leadership changes include the appointment of Karen Adams as COO, replacing Kanchan Thindal, to support CloudMD's growth and innovation goals.

CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF) announced the formation of a new Public Sector Division to enhance healthcare navigation and support. This division aims to address rising mental health issues and has secured significant contracts with the NYC Department of Education and North Carolina for opioid crisis support. CloudMD's diverse public sector client portfolio is expected to drive organic growth, while a recent expansion in mental health solutions introduced 107 new contracts. Leadership includes industry veterans with over 70 years of combined experience.

CloudMD Software & Services Inc. has officially qualified to trade on the OTCQX Best Market under the symbol DOCRF. This transition aims to enhance trading transparency for U.S. investors.

By meeting high financial standards and adhering to best corporate governance practices, CloudMD strengthens its visibility in the U.S. market. The company is committed to transforming healthcare delivery through technology, emphasizing patient-centric solutions that improve access and outcomes.